Erratum to: The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario
© The Author(s). 2017
Received: 17 February 2017
Accepted: 17 February 2017
Published: 28 March 2017
The original article was published in Harm Reduction Journal 2017 14:6
After publication of the original article , it was noted that one of the author’s name and affiliation was presented incorrectly. The correct name of the author (Nancy E. Lightfoot) and affiliation (2School of Rural and Northern Health, Laurentian University, 935 Ramsey Lake Rd., Sudbury, ON P3E 2C6, Canada) is published in this Erratum for quick reference. The original article was corrected. We apologise for any confusion this may have caused.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Franklyn AM, Eibl JK, Gauthier G, Pellegrini D, Lightfoot NE, Marsh DC. The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario. Harm Reduct J. 2017;14(6):1–9.Google Scholar